Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy

被引:0
|
作者
Anirban Mandal
Aparna Mukherjee
R. Lakshmy
Sushil K. Kabra
Rakesh Lodha
机构
[1] All India Institute of Medical Sciences,Department of Pediatrics
[2] All India Institute of Medical Sciences,Department of Cardiac Biochemistry
来源
关键词
HIV infection; Dyslipidemia; Lipodystrophy; Highly active antiretroviral therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:226 / 231
页数:5
相关论文
共 50 条
  • [1] Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy
    Mandal, Anirban
    Mukherjee, Aparna
    Lakshmy, R.
    Kabra, Sushil K.
    Lodha, Rakesh
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (03): : 226 - 231
  • [2] Dyslipidemia in a Cohort of HIV-infected Latin American Children Receiving Highly Active Antiretroviral Therapy*
    Brewinski, Margaret
    Megazzini, Karen
    Hance, Laura Freimanis
    Cashat Cruz, Miguel
    Pavia-Ruz, Noris
    Della Negra, Marinella
    Faleiro Ferreira, Flavia Gomes
    Marques, Heloisa
    Hazra, Rohan
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 2011, 57 (05) : 324 - 332
  • [3] DYSLIPIDEMIAS IN HIV-INFECTED CHILDREN AND ADOLESCENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
    Mancao, M.
    Abesamis, A.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 380 - 380
  • [4] Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy
    Miller, TL
    [J]. AIDS, 2003, 17 : S130 - S140
  • [5] Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy
    Abzug, Mark J.
    Song, Lin-Ye
    Fenton, Terence
    Nachman, Sharon A.
    Levin, Myron J.
    Rosenblatt, Howard M.
    Pelton, Stephen I.
    Borkowsky, William
    Edwards, Kathryn M.
    Peters, Jody
    [J]. PEDIATRICS, 2007, 120 (05) : E1190 - E1202
  • [6] Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy
    Nlend, A. E. Njom
    Loussikila, A. B.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2017, 47 (01): : 32 - 37
  • [7] Rosuvastatin for the treatment of dyslipidemia in HIV-infected patients receiving highly active antiretroviral therapy. Preliminary experience
    Gabriel Bottaro, Edgardo
    Caravello, Oscar
    Gustavo Scapellato, Pablo
    Stambulian, Marcela
    Ines Vidal, Gabriela
    Loggia, Veronica
    Luis Scapellato, Jose
    Thompson, Flavia
    Cassetti, Isabel
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 (06): : 325 - 329
  • [8] Vascular dysfunction in HIV infected patients receiving highly active antiretroviral therapy
    Ikonomidis, I.
    Palios, J.
    Lekakis, J.
    Rallidis, L.
    Tsiodras, S.
    Poulakou, G.
    Panagopoulos, P.
    Papadopoulos, A.
    Giamarellou, H.
    Kremastinos, D. T.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 366 - 366
  • [9] Anemia in HIV-infected patients receiving highly active antiretroviral therapy
    Moore, RD
    Forney, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01): : 54 - 57
  • [10] High rate of thyroid dysfunction in HIV-infected children receiving highly active antiretroviral therapy
    Viganò, A
    Riboni, S
    Bianchi, R
    Beccio, S
    Vago, T
    di Natale, B
    [J]. ANTIVIRAL THERAPY, 2002, 7 (03) : L62 - L63